BCAX
Bicara Therapeutics Inc.
$18.04
+$1.86(+11.50%)
75
Overall
60
Value
90
Tech
--
Quality
Market Cap
$852.95M
Volume
779.88K
52W Range
$7.80 - $22.68
Target Price
$32.57
Key Metrics Overview
| Market Cap | $852.95M | P/E Ratio | N/A |
| 52W High | $22.68 | 52W Low | $7.80 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 68.8% |
| Overall Score | 75 | Value Score | 60 |
| Quality Score | -- | Technical Score | 90 |
Growth Analysis
| EPS Current Est | $-2.55 | EPS Next Est | $-3.11 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $18.04 | +11.5% | 779.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW